R.P. Mueller - Concepedia

Author

R.P. Mueller

Also Known As

R MUELLER, R P Mueller, R. Mueller, R.-P. Mueller, R.P. Mueller, Rolf Mueller, Rolf P Mueller, Rolf P. Mueller, Rolf Peter Mueller

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Cologne University of Salzburg University Hospital Kralovske Vinohrady University of Würzburg Heidelberg University

About

R.P. Mueller is an author at University of Cologne specializing in oncology, cancer research, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	441
2	Health Sciences	2	2	52
3	Pathology	2	2	389
4	Radiation Medicine	1	1	14
5	Radiological Sciences	1	1	14

R.P. Mueller

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal Cancer Paul M. Schneider, Stephan Baldus, Ralf Metzger, Annals of Surgery	2005	370
Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial Bastian von Tresckow, Annette Plütschow, Michael Fuchs, Journal of Clinical Oncology	2012	311
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II S. Krege, J. Beyer, Rainer Souchon, European Urology Germ Cell CancerGenitourinary CancerMedicineCancer ManagementEuropean Consensus Conference	2008	252
Patterns of lymph node spread and its influence on outcome in resectable parotid cancer Tobias Ponert, R.P. Mueller, H. P. Dienes, European Journal of Surgical Oncology Surgical OncologyLymph Node SpreadMedicinePathologyResectable Parotid Cancer	2008	137
High Specificity of Quantitative <b> <i>Excision Repair Cross-Complementing 1</i> </b> Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer Ute Warnecke‐Eberz, Ralf Metzger, Futoshi Miyazono, Clinical Cancer Research	2004	109
High Cyclooxygenase-2 Expression Following Neoadjuvant Radiochemotherapy Is Associated with Minor Histopathologic Response and Poor Prognosis in Esophageal Cancer Huan Xi, Stephan Baldus, Ute Warnecke‐Eberz, Clinical Cancer Research	2005	64
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer Futoshi Miyazono, Ralf Metzger, Ute Warnecke‐Eberz, British Journal of Cancer	2004	47
Reduced Incidence of Nodal Micrometastasis after Major Response to Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer Klaus Prenzel, Alexandra König, Paul M. Schneider, Annals of Surgical Oncology Neoadjuvant ChemoradiationSurgical OncologyEsophageal CancerMedicineNodal Micrometastasis	2006	38
Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer Ute Warnecke‐Eberz, Shuichi Hokita, Huan Xi, Oncology Reports	2005	36
TaqMan <sup>®</sup> Low-Density Arrays and Analysis by Artificial Neuronal Networks Predict Response to Neoadjuvant Chemoradiation in Esophageal Cancer Ute Warnecke‐Eberz, Ralf Metzger, Elfriede Bollschweiler, Pharmacogenomics	2009	27

Page 1